UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 175 filers reported holding UNIQURE NV in Q3 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $109 | -95.4% | 16,100 | -92.2% | 0.00% | – |
| Q2 2023 | $2,370 | -98.9% | 206,715 | +1697.5% | 0.00% | – |
| Q3 2022 | $216,000 | -97.6% | 11,500 | -97.6% | 0.00% | -100.0% |
| Q2 2022 | $8,871,000 | +48.6% | 475,917 | +44.1% | 0.00% | 0.0% |
| Q1 2022 | $5,969,000 | -78.8% | 330,317 | -75.7% | 0.00% | -66.7% |
| Q4 2021 | $28,180,000 | -45.1% | 1,358,709 | -15.2% | 0.00% | -40.0% |
| Q3 2021 | $51,285,000 | -8.0% | 1,602,166 | -11.4% | 0.01% | 0.0% |
| Q2 2021 | $55,722,000 | -16.9% | 1,809,161 | -9.1% | 0.01% | -28.6% |
| Q1 2021 | $67,022,000 | -7.5% | 1,989,369 | -0.8% | 0.01% | 0.0% |
| Q4 2020 | $72,429,000 | +50.9% | 2,004,682 | +53.8% | 0.01% | +16.7% |
| Q3 2020 | $47,993,000 | +3.7% | 1,303,083 | +26.9% | 0.01% | 0.0% |
| Q2 2020 | $46,259,000 | +59.0% | 1,026,606 | +67.5% | 0.01% | +20.0% |
| Q1 2020 | $29,086,000 | -17.7% | 612,987 | +24.4% | 0.01% | 0.0% |
| Q4 2019 | $35,323,000 | +158.5% | 492,926 | +42.0% | 0.01% | +150.0% |
| Q3 2019 | $13,662,000 | -49.5% | 347,096 | +0.3% | 0.00% | -50.0% |
| Q2 2019 | $27,055,000 | +51.5% | 346,188 | +15.7% | 0.00% | +33.3% |
| Q1 2019 | $17,854,000 | +152.4% | 299,308 | +21.9% | 0.00% | +200.0% |
| Q4 2018 | $7,074,000 | -15.0% | 245,466 | +7.3% | 0.00% | 0.0% |
| Q3 2018 | $8,324,000 | – | 228,746 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |